Waters Stock Price, Forecast & Analysis (NYSE:WAT)

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its board has initiated a stock repurchase program on Tuesday, April 24th 2018, which permits the company to buyback $3,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 18.2% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board believes its shares are undervalued.

Waters Co. (NYSE:WAT) posted its earnings results on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share for the quarter, meeting the Zacks' consensus estimate of $2.13. The medical instruments supplier earned $577.28 million during the quarter, compared to analysts' expectations of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The firm's quarterly revenue was down .1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.92 EPS. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Waters.

Waters issued an update on its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million.

11 Wall Street analysts have issued 12 month target prices for Waters' stock. Their forecasts range from $177.00 to $260.00. On average, they anticipate Waters' share price to reach $208.73 in the next twelve months. This suggests that the stock has a possible downside of 4.1%. View Analyst Price Targets for Waters.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

News stories about WAT stock have been trending somewhat negative on Wednesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Waters earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Waters.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Alibaba Group (BABA), Honeywell International (HON), CVS Health (CVS), Raytheon (RTN), Cisco Systems (CSCO), QUALCOMM (QCOM), Procter & Gamble (PG) and Verizon Communications (VZ).

Waters' stock is owned by many different of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.65%), Marathon Asset Management LLP (0.69%), Beck Mack & Oliver LLC (0.58%), Newport Trust Co (0.45%), Boston Trust Walden Corp (0.43%) and Sumitomo Mitsui Trust Holdings Inc. (0.43%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including State of Tennessee Treasury Department, First Trust Advisors LP, Robecosam AG, Fenimore Asset Management Inc., Marathon Asset Management LLP, Harvey Investment Co. LLC, Triodos Investment Management BV and Beck Mack & Oliver LLC. Company insiders that have sold Waters company stock in the last year include Elizabeth B Rae, Ian King, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Anchor Capital Advisors LLC, State of New Jersey Common Pension Fund D, Assenagon Asset Management S.A., California Public Employees Retirement System, Ferguson Wellman Capital Management Inc., Boston Trust Walden Corp and First Quadrant L P CA. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $217.71.

Waters has a market capitalization of $14.03 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]